Q2 2017

Filed Aug 21, 2017 · 10-Q · 52 days after period end · 0001144204-17-044412

Q2 2017 · 10-Q

Revenue

$88.00K

−43.9% vs Q2 2016

Net Income

-$10.25M

N/M vs Q2 2016

EPS Diluted

-$0.05

N/M vs Q2 2016

Operating Income-$10,665,000N/M

Operating Cash Flow

Same quarter

Metric	Q2 2017	Q2 2016	Q2 2015	Q2 2014
Revenue	$88.00K	$157.00K	$391.00K	$0.00
Net Income	-$10.25M	-$14.18M	-$66.85M	-$25.87M
EPS Diluted	-$0.05	-$0.16	-$0.88	-$0.45

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Northwest Biotherapeutics Inc · CIK 1072379 · Engraved from SEC EDGAR